See change. Change in how you take measurements. Change in your ability to detect and monitor protein conformation. Change in how you collect, analyze and present results. Change for the better. At RedshiftBio, we help researchers see change better using our innovative tools and technologies.
Our origins are outside of the Life Sciences, but we are fast learners and listen closely to the needs of our customers. Being outsiders allowed us to see how new technologies from other fields could be combined to better solve problems within the Life Sciences. We developed our Microfluidic Modulation Spectroscopy (MMS) platform in response to a customer’s request for a better solution, and rather than repurpose outdated tools and methods designed originally for other applications, we started anew, and developed MMS from the ground up specifically with the protein scientist in mind.
In 2015, in response to the unique capabilities and potential of MMS, we pivoted our spectroscopy business to focus entirely on bringing innovative analytical solutions to the protein scientist. And so we are changing, too. Our RedShiftBio team now includes talented Life Science veterans, protein scientists and instrumentation engineers. We are financially backed by venture capitalists and Waters Corporation, a leading provider of analytical instrumentation for the life sciences with annual sales of over $2 billion. At RedShiftBio, we develop tools to help protein scientists see more clearly. And that’s definitely change for the better.
Chief Executive Officer
Chief Technology Officer
VP of Engineering
Chief Commercial Officer
RedShift™, RedShiftBio™, See Change™, and AQS3™ are trademarks of RedShift BioAnalytics, Inc.
Class 1 Laser Device Complies with 21 CFR Chapter 1, Subchapter J, Part 1040.10